Sample of topics under discussion at BSH/ISH 2016
What are the benefits of having different chronic lymphocytic leukemia (CLL) treatment options?
Monoclonal antibodies and checkpoint inhibitors for multiple myeloma
An overview of the current treatment landscape of non-Hodgkin lymphoma
The impact of new drugs and the changing role of transplants in multiple myeloma